Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Opko Health Inc (DE:XCY)
FRANKFURT:XCY
Opko Health (XCY) Stock Price & Analysis
1 Followers
XCY Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€0.79 - €1.93
Previous Close€1.12
Volume0.00
Average Volume (3M)N/A
Market Cap
€806.62M
Enterprise Value€1.01B
Total Cash (Recent Filing)$95.88M
Total Debt (Recent Filing)$308.75M
Price to Earnings (P/E)N/A
Beta0.56
Next Earnings
May 06, 2024EPS Estimate
-€0.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding696,991,667
10 Day Avg. Volume70
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)16.92
Price to Sales (P/S)0.95
Price to Cash Flow (P/CF)-5.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.17
Enterprise Value/Gross Profit2.41
Enterprise Value/Ebitda-13.63
Forecast
1Y Price Target
€2.99Price Target Upside167.31% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Opko Health News
PremiumCompany Announcements
Opko Health Sells Diagnostics Business to LabCorp
Bulls Say, Bears Say
Bulls Say
Financial Position & Capital AllocationThe sale of laboratory testing businesses provides non-dilutive capital to fund development of novel therapeutics for BioReference.
Market OpportunitiesPositive pharmacokinetic data for oral GLP-2 candidate developed by OPKO Health may position the company in a favorable spot within the $2.2B short bowel syndrome market.
Strategic Business MovesLabcorp acquires selected diagnostics assets from BioReference Health, allowing BioReference to focus on high-growth and high-margin operations.
Bears Say
Financial UncertaintyThe financial impact of the transaction on BRL segment margins is currently unclear, leaving some uncertainty in the valuation.
Operating PerformanceBRL's operating performance took a material step backwards in the quarter, with a significant operating loss.
Revenue IssuesDespite efforts at cost-cutting, BRL still recorded a substantial operating loss, indicating a serious revenue problem.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
0.02% Other Institutional Investors
99.98% Public Companies and
Individual Investors
XCY FAQ
What was Opko Health Inc’s price range in the past 12 months?
Opko Health Inc lowest stock price was €0.79 and its highest was €1.93 in the past 12 months.
What is Opko Health Inc’s market cap?
Currently, no data Available
When is Opko Health Inc’s upcoming earnings report date?
Opko Health Inc’s upcoming earnings report date is May 06, 2024 which is in 17 days.
How were Opko Health Inc’s earnings last quarter?
Opko Health Inc released its earnings results on Feb 27, 2024. The company reported -€0.085 earnings per share for the quarter, beating the consensus estimate of -€0.094 by €0.009.
Is Opko Health Inc overvalued?
According to Wall Street analysts Opko Health Inc’s price is currently Undervalued.
Does Opko Health Inc pay dividends?
Opko Health Inc does not currently pay dividends.
What is Opko Health Inc’s EPS estimate?
Opko Health Inc’s EPS estimate is -€0.09.
How many shares outstanding does Opko Health Inc have?
Currently, no data Available
What happened to Opko Health Inc’s price movement after its last earnings report?
Opko Health Inc reported an EPS of -€0.085 in its last earnings report, beating expectations of -€0.094. Following the earnings report the stock price went down -1.659%.
Which hedge fund is a major shareholder of Opko Health Inc?
Among the largest hedge funds holding Opko Health Inc’s share is Graham Capital Management, L.P.. It holds Opko Health Inc’s shares valued at 356K.
---
Opko Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€2.99 (167.31% Upside)
€2.99 (167.31% Upside)
Blogger Sentiment
Bullish
DE:XCY Sentiment 100%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth $5.9M over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-21.93%
12-Months-Change
Fundamentals
Return on Equity
-12.80%
Trailing 12-Months
Asset Growth
-7.18%
Trailing 12-Months
Company Description
Opko Health Inc
OPKO Health, Inc. engages in the provision of healthcare services. It operates through the Diagnostics and Pharmaceuticals segments. The Diagnostics segment comprises clinical laboratory operations which acquired through the Bio-Reference and point-of-care operations. The Pharmaceuticals segment includes the pharmaceutical operations acquired in Chile, Mexico, Ireland, Israel, and Spain; and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.
---
XCY Earnings Call
Q4 2024
0:00 / 0:00
---
XCY Stock 12 Months Forecast
Average Price Target
€2.99
▲(167.31% Upside)
Technical Analysis
Best Analysts Covering XCY
1 Year
1 Year Success Rate
11/34 ratings generated profit
1 Year Average Return
+7.70%
reiterated a buy rating 19 days ago
Copying Michael Petusky's trades and holding each position for 1 Year would result in 32.35% of your transactions generating a profit, with an average return of +7.70% per trade.
---